Expansion of tropism of a feline parvovirus to target a human tumor cell line by display of an αv integrin binding peptide on the capsid

Gene Therapy

Volumn 8, Issue 4, 2001, Pages 324-331

  Maxwell, I H ^a   Chapman, J T ^a   Scherrer, L C ^a   Spitzer, A L ^a   Leptihn, S ^a   Maxwell, F ^a   Corsini, J A ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Feline parvovirus; Human tumor cells; Integrin binding peptide; Retargeting; Rhabdomyosarcoma

Indexed keywords

ALPHA5 INTEGRIN; BINDING PROTEIN; CAPSID PROTEIN; INTEGRIN; LUCIFERASE; MONOCLONAL ANTIBODY; ONCOLYTIC VIRUS; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CAT DISEASE; CONTROLLED STUDY; GENE INSERTION; GENETIC TRANSDUCTION; INFECTION; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; REPORTER GENE; RHABDOMYOSARCOMA; SPECIES; TARGET CELL; TUMOR CELL LINE; VIRUS CAPSID; VIRUS RECOMBINANT;

ANTIGENS, CD; BREAST NEOPLASMS; CAPSID; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; ENDOTHELIUM, VASCULAR; FELINE PANLEUKOPENIA VIRUS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMANS; INTEGRIN ALPHA5; KERATINOCYTES; LIVER NEOPLASMS; LUCIFERASES; MELANOMA; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SKIN NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; DNA VIRUSES; FELIDAE; FELINE PANLEUKOPENIA VIRUS; FELINE PARVOVIRUS; FELIS CATUS; MIRIDAE; PAPOVAVIRIDAE; PARVOVIRUS;

EID: 0035087030     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301399     Document Type: Article

References (43)

1. The Parvoviruses
2. The autonomously replicating parvoviruses of vertebrates
3. Oncosuppression by parvoviruses
4. Autonomous parvovirus and densovirus gene vectors
5. The three-dimensional structure of canine parvovirus and its functional implications
6. Structure determination of feline panleukopenia virus empty particles
7. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles
8. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles
9. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
10. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells
11. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
12. αVβ5 integrin: A co-receptor for adeno-associated virus type 2 infection
13. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen
14. Integrins and cancer
15. Alpha v integrins as receptors for tumor targeting by circulating ligands
16. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin
17. Adhesion molecules in melanoma - More than just superglue?
18. Common principles in cell adhesion
19. RGD and other recognition sequences for integrins
20. Phage libraries displaying cyclic peptides with different ring sizes: Ligand specificities of the RGD-directed integrins
21. Species specificity for transduction of cultured cells by a recombinant LuIII rodent parvovirus genome encapsidated by canine parvovirus or feline panleukopenia virus
22. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells
23. Tropic determinant for canine parvovirus and feline panleukopenia virus functions through the capsid protein VP2
24. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library
25. Cell binding and internalization by filamentous phage displaying a cyclic Arg- Gly-Asp-containing peptide
26. Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma
27. Targeted adenovirus-mediated gene delivery to T-cells via CD3
28. Cloning and sequence of DNA encoding structural proteins of the autonomous parvovirus feline panleukopenia virus
29. The capsid determinant of fibrotropism for the MVMp strain of minute virus of mice functions via VP2 and not VP1
30. Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein
31. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
32. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
33. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody
34. Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy
35. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2
36. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
37. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
38. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus type 2
39. Nucleotide sequence of feline panleukopenia virus: Comparison with canine parvovirus identifies host-specific differences
40. Symmetric-strand packaging of recombinant parvovirus LuIII genomes that retain only the terminal regions
41. Linker-tailing: Unphosphorylated linker oligonucleotides for joining DNA termini
42. An adenovirus type 5 mutant with the preterminal protein gene deleted efficiently provides helper functions for the production of recombinant adeno-associated virus
43. Rapid titer determination using quantitative real-time PCR